| Q54573461 | 39 Determining covalent flavinylation |
| Q33873692 | A reversible monoamine oxidase A inhibitor, befloxatone: structural approach of its mechanism of action. |
| Q48010745 | Characterization of a highly conserved FAD-binding site in human monoamine oxidase B. |
| Q31062569 | Characterization of the human homolog of the IL-4 induced gene-1 (Fig1). |
| Q41726485 | Covalent attachment of flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) to enzymes: the current state of affairs |
| Q36048815 | Fig1, an interleukin 4-induced mouse B cell gene isolated by cDNA representational difference analysis |
| Q41283937 | Flavinylation of monoamine oxidase B. |
| Q28263664 | Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl |
| Q34047813 | Molecular characterization of monoamine oxidases A and B. |
| Q24614980 | Monoamine oxidase: from genes to behavior |
| Q28508376 | Renalase deficiency aggravates ischemic myocardial damage |
| Q27933793 | Saccharomyces cerevisiae is capable of de Novo pantothenic acid biosynthesis involving a novel pathway of beta-alanine production from spermine |